Intracerebroventricular guanine-based purines protect against seizures induced by quinolinic acid in mice

Neurochemical Research

Volumn 30, Issue 1, 2005, Pages 69-73

  Schmidt, André P ^a,b   Ávila, Thiago T ^a   Souza, Diogo O ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b NONE   (Brazil)

Author keywords

Excitotoxicity; Guanine based purines; Guanosine; Seizures

Indexed keywords

6,7 DINITRO 2,3 QUINOXALINEDIONE; DIZOCILPINE; GLUTAMATE RECEPTOR AGONIST; GUANOSINE; GUANOSINE 5' O (2 THIODIPHOSPHATE); GUANOSINE 5' O (3 THIOTRIPHOSPHATE); GUANOSINE DERIVATIVE; GUANOSINE DIPHOSPHATE; GUANOSINE PHOSPHATE; GUANOSINE TRIPHOSPHATE; GUANYLYLIMIDODIPHOSPHATE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR STIMULATING AGENT; PURINE; QUINOLINIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MEGADOSE; DRUG SCREENING; MALE; NEUROPROTECTION; NONHUMAN; PREMEDICATION; PRIORITY JOURNAL; RAT; TONIC CLONIC SEIZURE;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; GUANINE NUCLEOTIDES; INJECTIONS, INTRAVENTRICULAR; MALE; MICE; NEUROPROTECTIVE AGENTS; QUINOLINIC ACID; SEIZURES;

EID: 13844294355     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-004-9687-2     Document Type: Article

References (35)

1. Ozawa, S., Kamiya, H., and Tsuzuki, K. 1998. Glutamate receptors in the mammalian central nervous system. Prog. Neurobiol. 54:581-618.
2. Castellano, C., Cestari, V., and Ciamei, A. 2001. NMDA receptors and learning and memory processes. Curr. Drug Targets 2:273-283.
3. Lipton, S. A. and Rosemberg, P. A. 1994. Excitatory amino acids as a final common pathway for neurologic disorders. New Engl. J. Med. 330:613-622.
4. Heyes, M. P., Wyler, A. R., Devinsky, O., Yergey, J. A., Markey, S. P., and Nadi, N. S. 1990. Quinolinic acid concentrations in brain and cerebrospinal fluid of patients with intractable complex partial seizures. Epilepsia 31:172-177.
5. Nakano, K., Takahashi, S., Mizobuchi, M., Kuroda, T., Masuda, K., and Kitoh, J. 1993. High levels of quinolinic acid in brain of epilepsy-prone E1 mice. Brain Res. 619:195-198.
6. Meldrum, B. S. 1994. The role of glutamate in epilepsy and other CNS disorders. Neurology 44:S14-S23.
7. Schmidt, A. P., Lara, D. R., Maraschin, J. F., Perla, A. S., and Souza, D. O. 2000. Guanosine and GMP prevent seizures induced by quinolinic acid in mice. Brain Res. 864:40-43.
8. Ralevic, V. and Burnstock, G. 1998. Receptors for purines and pyrimidines. Pharmacol. Rev. 50:413-492.
9. Brundege, J. M. and Dunwiddie, T. V. 1997. Role of adenosine as a modulator of synaptic activity in the central nervous system. Adv. Pharmacol. 39:353-391.
10. Ciccarelli, R., Ballerini, P., Sabatino, G., Rathbone, M. P., D'Onofrio, M., Caciagli, F., and Di Iorio, P. 2001. Involvement of astrocytes in purine-mediated reparative processes in the brain. Int. J. Dev. Neurosci. 19:395-414.
11. Baron, B. M., Dudley, M. W., McCarty, D. R., Miller, F. P., Reynolds, I. J., and Schmidt. C. J. 1989. Guanine nucleotides are competitive inhibitors of N-Methyl-D-Aspartate at its receptor site both in vitro and in vivo. J. Pharmacol. Exp. Ther. 250:162-169.
12. Burgos, J. S., Barat, A., Souza, D. O., and Ramírez, G. 1998. Guanine nucleotides protect against kainate toxicity in an ex vivo chick retinal preparation. FEBS Lett. 430:176-180.
13. Paz, M. M., Ramos, M., Ramirez, G., and Souza, D. 1994. Differential effects of guanine nucleotides on kainic acid binding and on adenylate cyclase activity in chick optic tecturn. FEBS Lett. 355:205-208.
14. Regner, A., Ramírez, G., Belló-Klein, A., and Souza, D. O. 1998. Effects of guanine nucleotides on glutamate-induced chemiluminescence in rat hippocampal slices submitted to hypoxia. Neurochem. Res. 23:519-524.
15. Frizzo, M. E. S., Lara, D. R., Dahm, K. C. S., Prokopiuk, A. S., Swanson, R., and Souza, D. O. 2001. Activation of glutamate uptake by guanosine in primary astrocyte cultures. NeuroReport 12:879-881.
16. Frizzo, M. E. S., Lara, D. R., Prokopiuk, A. S., Vargas, C. R., Salbego, C. G., Wajner, M., and Souza, D. O. 2002. Guanosine enhances glutamate uptake in brain cortical slices at normal and excitotoxic conditions. Cell. Mol. Neurobiol. 22:353-363.
17. Frizzo, M. E. S., Soares, F. A., Dall'Onder, L. P., Lara, D. R., Swanson, R. A., and Souza, D. O. 2003. Extracellular conversion of guanine-based purines to guanosine specifically enhances astrocyte glutamate uptake. Brain Res. 972:84-89.
18. Paas, Y., Devillers-Thiery, A., Changeux, J. P., Medevielle, F., and Teichberg, V. I. 1996. Identification of an extracellular motif involved in the binding of guanine nucleotides by a glutamate receptor. EMBO J. 15:1548-1556.
19. Souza, D. O., Frizzo, M. E. S., and Lara, D. R. 2000. Glutamate uptake enhanced by guanosine in vitro: possible neuroprotective mechanism against hypoxia/hypoglycemia injury. Drug Dev. Res. 50:115.
20. Caciagli, F., Di Iorio, P., Giuliani, P., Middlemiss, M. P., and Rathbone, M. P. 2000. The neuroprotective activity of guanosine involves the production of trophic factors and the outflow of purines from astrocytes. Drug Dev. Res. 50:32.
21. Lara, D. R., Schmidt, A. P., Frizzo, M. E. S., Burgos, J. S., Ramirez, G., and Souza, D. O. 2001. Effect of orally administered guanosine on seizures and death induced by glutamatergic agents. Brain Res. 912:176-180.
22. Soares, F. A., Schmidt, A. P., Farina, M., Frizzo, M. E., Tavares, R. G., Portela, L. V., Lara, D. R., and Souza, D. O. 2004. Anticonvulsant effect of GMP depends on its conversion to guanosine. Brain Res. 1005:182-186.
23. Vinadé, E. R., Schmidt, A. P., Frizzo, M. E. S., Izquierdo, I., Elizabetsky, E., and Souza, D. O. 2003. Chronically administered guanosine is anticonvulsant, amnesic and anxiolytic in mice. Brain Res. 977:97-102.
24. Haley, T. J. and McCormick, W. G. 1957. Pharmacologic effects of intracerebral injection of drugs in conscious mouse. Br. J. Pharmacol. 12:12-15.
25. Hallak, M., Irtenkauf, S. M., Janusz, C. A., and Cotton, D. B. 1993. Stimulation and inhibition of N-methyl-D-aspartate receptors in rats: developing a seizure model. Am. J. Obstet. Gynecol. 169:695-700.
26. Rubin, M. A., Jurach, A., Costa, E. M., Lima, T. T., Jimenez-Bernal, R. E., Begnini, J., Souza, D. O., and Mello, C. F. 1996. GMP reverses the facilitatory effect of glutamate on inhibitory avoidance task in rats. NeuroReport 7:2078-2080.
27. Malcon, C., Achaval, M., Komlos, F., Partata, W., Sauressig, M., Ramirez, G., and Souza, D. O. 1997. GMP protects against quinolinic acid-induced loss of NADPH-diaphorase-positive cells in the rat striatum. Neurosci. Lett. 225:145-148.
28. Roesler, R., Vianna, M. R., Lara, D. R., Izquierdo, I., Schmidt, A. P., and Souza, D. O. 2000. Guanosine impairs inhibitory avoidance performance in rats. NeuroReport 11:2537-2540.
29. Vinade, E. R., Izquierdo, I., Lara, D. R., Schmidt, A. P., and Souza, D. O. 2004. Oral administration of guanosine impairs inhibitory avoidance performance in rats and mice. Neurobiol. Learn. Mem. 81:137-143.
30. Oliveira, I. J., Molz, S., Souza, D. O., and Tasca, C. I. 2002. Neuroprotective effect of GMP in hippocampal slices submitted to an in vitro model of ischemia. Cell. Mol. Neurobiol. 22:335-344.
31. Rotta, L. N., Schmidt, A. P., Melo e Souza, T., Nogueira, C. W., Souza, K. B., Izquierdo, I. A., Perry, M. L., and Souza, D. O. 2003. Effects of undernutrition on glutamatergic parameters in rat brain. Neurochem. Res. 28:1181-1186.
32. Tasca, C. I., Santos, T. G., Tavares, R. G., Battastini, A. M., Rocha, J. B., and Souza, D. O. 2004. Guanine derivatives modulate L-glutamate uptake into rat brain synaptic vesicles. Neurochem. Int. 44:423-431.
33. Ciccarelli, R., Di Iorio, P., Giuliani, P., D'Alimonte, I., Ballerini, P., Caciagli, F., and Rathbone, M. P. 1999. Rat cultured astrocytes release guanine-based purines in basal conditions and after hypoxia/hypoglycemia. Glia 25:93-98.
34. 3H)-guanosine binding sites in rat brain membranes. Br. J. Pharmacol. 135:969-976.
35. Tasca, C. I., Cardoso, L. F., Martini, L. H., and Souza, D. O. 1998. Guanine nucleotides inhibit cAMP accumulation induced by metabotropic glutamate receptor activation. Neurochem. Res. 23:183-188.